Protective effects of maternal nutritional supplementation with lactoferrin on growth and brain metabolism

Pediatric Research

Volumn 75, Issue 1, 2014, Pages 51-61

  Somm, Emmanuel ^a   Larvaron, Pierre ^a   Van De Looij, Yohan ^a,b   Toulotte, Audrey ^a   Chatagner, Alexandra ^a   Faure, Magali ^c   Métairon, Sylviane ^c   Mansourian, Robert ^c   Raymond, Frédéric ^c   Gruetter, Rolf ^b   Wang, Bing ^c,d   Sizonenko, Stéphane V ^a   Hüppi, Petra S ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b EPFL   (Switzerland)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

^d CHARLES STURT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; DEXAMETHASONE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; LACTOFERRIN; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH; BODY WEIGHT; BRAIN DEVELOPMENT; BRAIN METABOLISM; CATCH UP GROWTH; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD; GENE EXPRESSION; GROWTH; HIPPOCAMPUS; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; LACTATION; MATERNAL NUTRITION; MATERNAL NUTRITIONAL SUPPLEMENTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ANIMALS; BODY WEIGHT; BRAIN; DEXAMETHASONE; DIETARY SUPPLEMENTS; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION; GROWTH; LACTATION; LACTOFERRIN; POLYMERASE CHAIN REACTION; PREGNANCY; RATS; WEIGHT GAIN;

EID: 84893254174     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.199     Document Type: Article

References (45)

1. World health statistics report 2012. http://www.who.int/gho/publications/ world-health-statistics/EN-WHS2012-Fullpdf.
2. Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: Strength of effects and biological basis. Int J Epidemiol 2002;31:1235-9.
3. Latal-Hajnal B, von Siebenthal K, Kovari H, Bucher HU, Largo RH. Postnatal growth in VLBW infants: Significant association with neurodevelopmental outcome. J Pediatr 2003;143:163-70.
4. Mallard C, Loeliger M, Copolov D, Rees S. Reduced number of neurons in the hippocampus and the cerebellum in the postnatal guinea-pig following intrauterine growth-restriction. Neuroscience 2000;100:327-33.
5. Lodygensky GA, Seghier ML, Warfield SK, et al. Intrauterine growth restriction affects the preterm infants hippocampus. Pediatr Res 2008;63: 438-43.
6. Modi N, Lewis H, Al-Naqeeb N, Ajayi-Obe M, Dore CJ, Rutherford M. The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr Res 2001;50:581-5.
7. Somm E, Vauthay DM, Guerardel A, et al. Early metabolic defects in dexamethasone-exposed and undernourished intrauterine growth restricted rats. PLoS ONE 2012;7:e50131.
8. Noorlander CW, Visser GH, Ramakers GM, Nikkels PG, De Graan PN. Prenatal corticosteroid exposure affects hippocampal plasticity and reduces lifespan. Dev Neurobiol 2008;68:237-46.
9. Nagasawa T, Kiyosawa I, Kuwahara K. Amounts of lactoferrin in human colostrum and milk. J Dairy Sci 1972;55:1651-9.
10. Garcia-Montoya IA, Cendon TS, Arevalo-Gallegos S, Rascon-Cruz Q. Lactoferrin a multiple bioactive protein: An overview. Biochim Biophys Acta 2012;1820:226-36.
11. Manzoni P, Rinaldi M, Cattani S, et al.; Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial. JAMA 2009;302:1421-8.
12. Fillebeen C, Dexter D, Mitchell V, et al. Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. Adv Exp Med Biol 1998;443:293-300.
13. An L, Sato H, Konishi Y, et al. Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimers disease. Neurosci Lett 2009;452:277-80.
14. Ji B, Maeda J, Higuchi M, et al. Pharmacokinetics and brain uptake of lactoferrin in rats. Life Sci 2006;78:851-5.
15. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res 1990;53:157-67.
16. Wu SC, Chen HL, Yen CC, et al. Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance. J Agric Food Chem 2007;55:4670-7.
17. Burrin DG, Wang H, Heath J, Dudley MA. Orally administered lactoferrin increases hepatic protein synthesis in formula-fed newborn pigs. Pediatr Res 1996;40:72-6.
18. Liao Y, Jiang R, Lonnerdal B. Biochemical and molecular impacts of lactoferrin on small intestinal growth and development during early life. Biochem Cell Biol 2012;90:476-84.
19. Ronayne De Ferrer PA, Baroni A, Sambucetti ME, Lopez NE, Ceriani Cernadas JM. Lactoferrin levels in term and preterm milk. J Am Coll Nutr 2000;19:370-3.
20. Cornish J, Callon KE, Naot D, et al. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 2004;145:4366-74.
21. Antonio I, Valeria B, Maddalena G, Giovanni T. Immunohistochemical evidence of lactoferrin in human embryo-fetal bone and cartilage tissues. Cell Biol Int 2010;34:845-9.
22. Moreno-Navarrete JM, Ortega FJ, Ricart W, Fernandez-Real JM. Lactoferrin increases (172Thr)AMPK phosphorylation and insulin-induced (p473Ser)AKT while impairing adipocyte differentiation. Int J Obes (Lond) 2009;33:991-1000.
23. Moreno-Navarrete JM, Ortega F, Sabater M, Ricart W, Fernandez-Real JM. Proadipogenic effects of lactoferrin in human subcutaneous and visceral preadipocytes. J Nutr Biochem 2011;22:1143-9.
24. Saigal S, Pinelli J, Hoult L, Kim MM, Boyle M. Psychopathology and social competencies of adolescents who were extremely low birth weight. Pediatrics 2003;111(5 Pt 1):969-75.
25. Yi SJ, Masters JN, Baram TZ. Glucocorticoid receptor mRNA ontogeny in the fetal and postnatal rat forebrain. Mol Cell Neurosci 1994;5: 385-93.
26. Barbany G, Persson H. Regulation of Neurotrophin mRNA Expression in the Rat Brain by Glucocorticoids. Eur J Neurosci 1992;4:396-403.
27. Hossain A, Hajman K, Charitidi K, et al. Prenatal dexamethasone impairs behavior and the activation of the BDNF exon IV promoter in the paraventricular nucleus in adult offspring. Endocrinology 2008;149:6356-65.
28. Cosi C, Spoerri PE, Comelli MC, Guidolin D, Skaper SD. Glucocorticoids depress activity-dependent expression of BDNF mRNA in hippocampal neurones. Neuroreport 1993;4:527-30.
29. Kumamaru E, Numakawa T, Adachi N, et al. Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase. Mol Endocrinol 2008;22:546-58.
30. Numakawa T, Kumamaru E, Adachi N, Yagasaki Y, Izumi A, Kunugi H. Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-gamma signaling for glutamate release via a glutamate transporter. Proc Natl Acad Sci USA 2009;106:647-52.
31. Zhao J, Ramadan E, Cappiello M, Wroblewska B, Bzdega T, Neale JH. NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance. Eur J Neurosci 2001;13: 340-6.
32. Westbrook GL, Mayer ML, Namboodiri MA, Neale JH. High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture. J Neurosci 1986;6:3385-92.
33. Bergeron R, Imamura Y, Frangioni JV, Greene RW, Coyle JT. Endogenous N-acetylaspartylglutamate reduced NMDA receptor-dependent current neurotransmission in the CA1 area of the hippocampus. J Neurochem 2007;100:346-57.
34. Bliss TV, Collingridge GL. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 1993;361:31-9.
35. Schober ME, McKnight RA, Yu X, Callaway CW, Ke X, Lane RH. Intrauterine growth restriction due to uteroplacental insufficiency decreased white matter and altered NMDAR subunit composition in juvenile rat hippocampi. Am J Physiol Regul Integr Comp Physiol 2009;296:R681-92.
36. Neeley EW, Berger R, Koenig JI, Leonard S. Strain dependent effects of prenatal stress on gene expression in the rat hippocampus. Physiol Behav 2011;104:334-9.
37. Dallas PB, Gottardo NG, Firth MJ, et al. Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR-how well do they correlate BMC Genomics 2005;6:59.
38. Schelshorn DW, Schneider A, Kuschinsky W, et al. Expression of hemoglobin in rodent neurons. J Cereb Blood Flow Metab 2009;29:585-95.
39. Van Den Hove DL, Steinbusch HW, Bruschettini M, et al. Prenatal stress reduces S100B in the neonatal rat hippocampus. Neuroreport 2006;17:1077-80.
40. Yamauchi K, Toida T, Nishimura S, et al. 13-Week oral repeated administration toxicity study of bovine lactoferrin in rats. Food Chem Toxicol 2000;38:503-12.
41. Cerven D, DeGeorge G, Bethell D. 28-day repeated dose oral toxicity of recombinant human holo-lactoferrin in rats. Regul Toxicol Pharmacol 2008;52:174-9.
42. Paesano R, Torcia F, Berlutti F, et al. Oral administration of lactoferrin increases hemoglobin and total serum iron in pregnant women. Biochem Cell Biol 2006;84:377-80.
43. Williams K, Wilson MA, Bressler J. Regulation and developmental expression of the divalent metal-ion transporter in the rat brain. Cell Mol Biol (Noisy-le-grand) 2000;46:563-71.
44. Carlson ES, Tkac I, Magid R, et al. Iron is essential for neuron development and memory function in mouse hippocampus. J Nutr 2009;139: 672-9.
45. Georgieff MK. The role of iron in neurodevelopment: Fetal iron deficiency and the developing hippocampus. Biochem Soc Trans 2008;36 (Pt 6):1267-71.